AcuityAds gets price target raise to $4.40 at Echelon Wealth

AcuityAds CEO Tal Hayek.

Blowout preliminary fourth quarter results are a sign that there is still upside left in AcuityAds (AcuityAds Stock Quote, Chart, News: TSXV:AT), says Echelon Wealth Partners analyst Rob Goff.

On January 17, AcuityAds reported prelimary Q4 results that said the company expects to report EBITDA of approximately $2.0-million on revenue of approximately $18.0-million. The number were far above the street consenus and last year’s fourth quarter results.

“Based on these preliminary results, Q4 is expected to be an exceptionally strong quarter for the company,” said CEO Tal Hayek. “Our strong revenue and EBITDA growth, along with our recent $4.6-million bought-deal financing, should position the company well to capitalize on the tremendous opportunities that lie ahead of us.”

Goff thinks this upside surprise is not just a one-off.

“We feel confident that the revenue momentum reported with the preliminary Q416 results was sufficient to warrant a positive revaluation given the prospects of positive forecast revisions and the Company’s enhanced ability to complete accretive acquisitions building on the success of 140 Proof,” he says. “We believe our revenues leave upside while our EBITDA (modestly below some) allows for further expansion-driven investments. We believe AcuityAds’ revenue momentum reflects on market and product strength but also the consideration that the Company now has a relatively full sales team with traction. The Company was previously in more of a start-up growth mode where it worked to expand sales while pruning those where initial traction had disappointed. Goff added: “We, in turn, believe the Company’s revenue momentum and newfound scale make it an increasingly attractive acquisition target.

In a research update to clients today, Goff maintained his “Speculative Buy” rating on AcuityAds, but raised his one-year price target on the stock from $3.90 to $4.40, implying a return of 14.6 per cent at the time of publication.

Goff believes AcuityAds will post EBITDA of $2.7-million on revenue of $39.1-million in fiscal 2016. He expects these numbers will improve to EBITDA of $4.4-million on a topline of $58.6-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: at
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

10 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

17 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

18 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

18 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

2 days ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago